Fostering an international evidence-based consensus on risk assessment and developing management tools in food allergy
Food allergies are of high and growing importance to public health, affecting consumers’ quality of life and resulting in increasing calls on health service resources. There is growing evidence that this impact is increasing at a global level as developing countries adopt a ‘Western’ lifestyle. Minimising the risk from allergenic foods is a shared responsibility of all the stakeholders involved (e.g. patients, clinicians, food manufacturers, retailers, caterers and regulators).
This task force aims to foster an international evidence-based consensus on how to assess the risk of allergenic foods and develop the tools which will help to manage this risk.
- The Food Allergy Task Force was the first to propose dose distribution modelling as an approach to characterising and subsequently assessing the risk posed by food allergens. The task force created a framework for new thinking on food allergy risks and contributed to the acceptance of risk assessment-based approaches for food allergens.
- The task force made significant contributions to the VITAL (Voluntary Incidental Trace Allergen Labelling) scientific expert panel and the development of reference doses for allergens.
- The task force and its expert groups are comprised of a strong network of international world-class experts from leading organisations such as the Food Allergy Research & Resource Program (FARRP) and the European Academy of Allergy and Clinical Immunology (EAACI). The task force has been acknowledged as a reliable and valuable partner by national regulators (e.g. governmental institutions/authorities), leading clinicians, patient organisations and established industry players in the field.
- Three papers describing the conclusions of the 2012 ILSI Europe workshop ‘Thresholds to Action Levels’ have been published in Food and Chemical Toxicology (S. Hattersley, et al. 2014; R.W.R. Crevel, et al. 2014a; R.W.R. Crevel, et al. 2014b) and disseminated via a webinar on ‘Allergen Risk Assessment and Reference Doses' on 16 April 2015.
• New Expert Group on ‘Verifying VITAL®2.0 Reference Doses: Suitability of Analytical Methods’.
• New publication on Prioritisation of Allergenic Foods with Respect to Public Health Relevance (G. Houben, et al. 2016).
For more detailed information, please contact Dr Estefanía Noriega at email@example.com